Leveraging cutting-edge genomic profiling technology to advance cancer care
Geneseeq is a research-driven company that provides next generation sequencing (NGS) technology to accelerate precision cancer care. With headquarters in both Canada and China, Geneseeq focuses on clinical genetic testing and translational research covering all cancers and sample types. The company provides a full suite of next generation sequencing services to facilitate the research and creative endeavors of those in academia and industry. The company offers both pan-cancer panels analyzing more than 400 genes and cancer-type specific gene panels to help match patients to optimal treatments, including targeted therapy and immunotherapy.
Click on the featured content below to learn how Geneseeq, in collaboration with IDT, is accelerating precision cancer research!